drugset / Trial / NCT00726245

Plasma Rich in Growth Factors (PRGF) Treatment for Muscle Tear

NCT00726245 ↗

Phase 2/3 Completed 50 enrolled Meir Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

the improvement of symptoms and disease progress by the treatment of OA of the knee with PRGF

Timeline

Start
2008-01
Primary completion
2009-02
Completion
2011-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Plasma Rich in Growth Factors Unknown 3 mg Intramuscular
Subject Plasma Rich in Growth Factors Unknown 6 mg Intramuscular

Indications

No indication recorded.